All In Biotech

Drug Trial Radar · NCT06247085

Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment

A Phase 3, Parallel-Group Treatment, Blinded, Randomized, Placebo-Controlled Study To Assess The Efficacy And Safety Of Pegtibatinase Administered Subcutaneously In Addition To Standard Of Care In Participants With Classical Homocystinuria Due To Cystathionine Beta Synthase Deficiency (HARMONY)

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Dec 28, 2023

Primary completion

Aug 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Travere Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Feb 7, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers are looking for a better way to treat people living with classical homocystinuria (HCU), a rare inherited condition. It is caused by changes in the cystathionine beta-synthase (or "CBS") gene and prevents an enzyme from working correctly in the body. This enzyme helps break down homocysteine, which is produced when the body processes methionine from protein-containing foods. This helps keep homocysteine and methionine at healthy levels. When this enzyme is not working, homocysteine and methionine build up in the blood and then spread into different tissues of the body and stop these body tissues from working normally. People living with HCU can experience problems with their vision, bones, blood vessels, thinking, learning, and memory. Available treatments for HCU include a low-methionine diet (typically achieved by limiting protein-containing foods), a methionine-free protein supplement to help meet daily protein needs, and betaine (Cystadane®). These treatments are either not sufficient or are hard to take for many patients. Pegtibatinase was designed by researchers to act like the CBS enzyme, which is missing or not working properly in people living with HCU. Researchers are studying whether adding pegtibatinase to standard treatment can lower homocysteine levels. Researchers want to learn how safe and effective pegtibatinase is, how it moves through and affects the body, and how it may affect the daily lives of people with HCU. The study plans to enroll participants from the US, Australia, Belgium, France, Germany, Ireland, Italy, Poland, Portugal, Qatar, Saudi Arabia, Spain, Turkey, and the United Kingdom. Many study visits may happen at home, depending on where you live and local regulations. Some visits may include a home nurse and telemedicine appointments with the study doctor.

Conditions

  • Homocystinuria

Interventions

  • PegtibatinaseDrug

    Pegtibatinase BIW

  • PlaceboOther

    volume-matched saline SC BIW

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in plasma tHcy levels - Weeks 6 to 12Time frame: Weeks 6 - 12

Locations

52 sites in 14 countries. Site status is shown where the registry gives one.

  • Phoenix Children's Hospital

    Phoenix, Arizona · Recruiting

  • Yale University School of Medicine

    New Haven, Connecticut · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois · Recruiting

  • Maine Health - Maine Medical Center

    Portland, Maine · Recruiting

  • Uncommon Cures

    Chevy Chase, Maryland · Recruiting

  • The Mount Sinai Hospital

    New York, New York · Recruiting

  • Science 37 - Virtual Site

    Morrisville, North Carolina · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Not yet recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Utah Health - The University of Utah Primary Children's Hospital

    Salt Lake City, Utah · Recruiting

  • Royal Adelaide Hospital

    Adelaide, Australia · Recruiting

  • Royal Children's Hospital Melbourne

    Parkville, Australia · Recruiting

  • Westmead Hospital

    Westmead, Australia · Recruiting

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium · Recruiting

  • Universitair Ziekenhuis Antwerpen (UZA)

    Edegem, Belgium · Recruiting

  • Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Necker-Enfants Malades

    Paris, France · Recruiting

  • CHRU Hôpitaux de Tours - Hôpital Bretonneau

    Tours, France · Recruiting

  • Centre Hospitalier Régional Universitaire de Nancy (CHRU) - Hopitaux de Brabois - Hôpital d'enfants

    Vandœuvre-lès-Nancy, France · Recruiting

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, Germany · Not yet recruiting

  • Universitätsklinikum Leipzig

    Leipzig, Germany · Not yet recruiting

  • Universitätsklinikum Münster

    Münster, Germany · Not yet recruiting

  • Children's Health Ireland (CHI) at Temple Street

    Dublin, Ireland · Recruiting

  • Ospedale Pediatrico Giovanni XXIII

    Bari, Italy · Not yet recruiting

  • IRCCS Istituto Giannina Gaslini

    Genova, Italy · Not yet recruiting

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Policlinico di Milano)

    Milan, Italy · Not yet recruiting

  • Fondazione IRCCS San Gerardo Dei Tintori - Ospedale San Gerardo

    Monza, Italy · Not yet recruiting

  • Azienda Ospedaliera di Padova

    Padova, Italy · Not yet recruiting

  • SP ZOZ Szpital Uniwersytecki w Krakowie

    Krakow, Poland · Not yet recruiting

  • Instytut Matki i Dziecka

    Warsaw, Poland · Not yet recruiting

  • Instytut Pomnik-Centrum Zdrowia Dziecka

    Warsaw, Poland · Recruiting

  • Unidade Local de Saúde de Coimbra, EPE - Hospitais da Universidade de Coimbra

    Coimbra, Portugal · Recruiting

  • Unidade Local de Saúde de Santa Maria, EPE - Hospital de Santa Maria

    Lisbon, Portugal · Recruiting

  • Unidade Local de Saúde de São João, EPE - Hospital São João

    Porto, Portugal · Not yet recruiting

  • Hamad General Hospital

    Doha, Qatar · Recruiting

  • Sidra Hospital

    Doha, Qatar · Recruiting

  • King Abdullah International Medical Research Center

    Riyadh, Saudi Arabia · Recruiting

  • King Faisal Specialist Hospital and Research Centre (KFSHRC) - Riyadh

    Riyadh, Saudi Arabia · Recruiting

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.